Patents/Inventors

Thomas Kuilman

AmstelveenNL1 patent

2 Patents

US124923862025
Methods to Enrich Genetically Engineered T Cells
NEOGENE THERAPEUTICS B.V.
0 cites
US116291792023
Tweak-receptor Agonists for Use in Combination with Immunotherapy of a Cancer
Stichting Het Nederlands Kanker Instituut—antoni Van Leeuwenhoek Ziekenhuis
0 cites